British companies to develop new crown rapid detection technology: just fingertip blood, 10 minutes

Two BRITISH COMPANIES HAVE INDEPENDENTLY DEVELOPED TWO TESTKITS TO TEST THE NEW CORONARY PNEUMONIA VIRUS IN JUST 10 MINUTES. Public Health England has changed its previous approach to the new rapid detection device for coronary pneumonia, admitting that it is evaluating both test kits. SureScreen Diagnostics has developed a new coronal pneumonia test kit with 98% accuracy.

British companies to develop new crown rapid detection technology: just fingertip blood, 10 minutes

The company said its testkits had been approved and would be used in the UK, Ireland, Germany, Spain, Switzerland, the Netherlands, Turkey, the United Arab Emirates, Kuwait and Oman.

Another British company, Called Mologic, is developing a cheap test kit that can be tested in just 10 minutes and will be used to stem the spread of the epidemic in Africa.

Mologic is funded by the UK’s New Crown Pneumonia Research Fund, which is worth a million pounds.

Mologic is expected to develop a quick test kit that takes only 10 minutes in about three months for less than $1.

The accuracy of these two test kits is less reassuring, so people who test positive can go to the official testing agency for review.

Public Health England, concerned that their accuracy is not high enough, yesterday warned people to be cautious about using such testing equipment, saying it “has little information on the accuracy of these two test kits.”

But a spokesman told MailOnline today that Public Health England was “evaluating a number of commercial new crown pneumonia testing equipment, but will not endorse commercial products under review.”

“We’ve been working hard to develop a public-friendly test kit that can produce results in 10 minutes with just a few drops of blood collected from our fingertips,” said David Campbell, director of SureScreen Diagnostics. “

It is estimated that about 175,000 people have been tested for the new coronary pneumonia virus using the SureScreen Diagnostics test kit, and next month more than 2 million sureScreen Diagnostics test kits will be ordered.

SureScreen Diagnostics did not comment.

Other companies and research institutes are also developing rapid detection kits for new coronary pneumonia.

Mologic, based in Bedford, receives government funding for the development of rapid detection kits and works with partners in Senegal.

So far, the outbreak of new coronary pneumonia in Africa has not been severe. Nigeria has a population of 200 million and only five laboratories can detect the new coronary pneumonia virus.

Mologic has previously developed rapid testing kits for Ebola, measles and yellow fever. Mologic’s new coronary pneumonia rapid detection kit is expected to be completed in June.

Many research institutions are developing faster new coronary pneumonia testkits.

Researchers at the University of Northumbria have developed a breath-testing device that can quickly detect people infected with the virus. They say the technology can be used to quickly screen passengers at airports. At present, the detection time of the new coronary pneumonia virus in the UK is between 24 and 48 hours.

The Northumbria Team’s detection techniques detect biomarker information in breath samples. These biomarkers, including DNA, RNA, proteins and fat molecules, can be used to detect lesions in the lungs and other organs of the body.

The subject snorted to the device in a manner similar to the alcohol meter used by the traffic police to check the drink-driving. “Our goal is that blood samples are no longer needed in mass screening,” said Sterghios Moschos, an assistant teaching assistant at Northumbria University. “